Topic List : Cancer
Researchers create tool to help unravel secrets of cancer
Using novel methods, scientists have identified biological signatures in cancer cells that can be traced back to the original cancer gene.
Inhibiting protein family helps mice survive radiation exposure, study finds
Tinkering with a molecular pathway that governs how intestinal cells respond to stress can help mice survive a normally fatal dose of abdominal radiation, according to a new study by researchers at the Stanford University School of Medicine.
Seung Kim awarded prestigious Ho-Am Prize in Medicine
Seung Kim Seung Kim, MD, PhD, professor of developmental biology and a Howard Hughes Medical Institute investigator, has been named the winner of the 2014 Ho-Am Prize in Medicine.
Technique allows for radiation-free detection of tumors, study finds
Heike Daldrup-Link Researchers at the Stanford University School of Medicine and Lucile Packard Children’s Hospital Stanford have developed a way to scan young cancer patients’ bodies for tumors without exposing them to radiation.
Oral anti-fungal drug can treat skin cancer in patients, study shows
Jean Tang Decades of research and millions of dollars go into developing new cancer drugs from scratch.
Chemists develop new technique for improving stomach cancer surgery results
Livia Eberlin, a postdoctoral scholar in chemistry, examines a stained sample against a backdrop of images from gastric cancer surgery and the mass spectrometer she uses in her interdisciplinary research.
Medical school awarded $90 million from Ludwig Cancer Research
The School of Medicine has received $90 million from Ludwig Cancer Research on behalf of its founder, Daniel K.
Workshop helps oncology physicians improve communication skills
Jonathan Berek One of hardest parts of a doctor's job — delivering bad news to patients and their loved ones — is rarely addressed in medical school.
5 Questions: Beverly Mitchell on advances in cancer care
Beverly Mitchell In the past few years, there have been dramatic advances in the use of genomic analysis, molecular biology, imaging technologies and data management to make cancer treatment less toxic and better tailored to individual patients.
Study explains why drug may help more cancer patients
Maximilian Diehn Recently some intriguing data has suggested that breast cancer patients whose tumors appear insensitive to a class of drugs known as anti-HER2 medications (the drug trastuzumab, marketed as Herceptin, is a well-known example) may somehow still benefit from treatment with the medication.